MDB Capital Holdings (MDBH) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
The platform is scaling to increase company launches from one every 18 months to three to five per year, aiming to build a diversified public venture portfolio and drive stakeholder value.
Maintains a 28-year track record with a 100% IPO success rate, with all launched companies trading at a premium to IPO price.
Two company launches (Pollex/Paulex Bio and Buda Juice) are expected to close soon, marking the first time two launches occur in one quarter.
Expanded pipeline of early-stage, disruptive companies and broadened investor base with new investors from TCA Venture Group and Keiretsu Forum MST.
Operates two main segments: broker dealer & intellectual property services, and technology development, with a shift in 2025 after deconsolidating eXoZymes post-IPO.
Financial highlights
Operating expenses for the first three quarters totaled $5.9 million; net cash used in operational activities was approximately $5.9 million through the first three quarters of 2025.
Net loss attributable to members was $19.5M for the nine months ended September 30, 2025.
Anticipated closings of Paulex Bio private placement ($16.8M) and Buda Juice IPO ($20M) expected to generate positive cash and add to equity holdings.
Equity in exoZymes Inc. (NASDAQ: EXOZ) valued at $38.7M GAAP, with a mark-to-market value of $59.2M as of September 30, 2025.
Cash and cash equivalents at September 30, 2025, were $15.1M, down from $20.4M at year-end 2024.
Outlook and guidance
Management expects a strong fourth quarter and anticipates achieving three to five company launches in the next year, with a robust pipeline and four to five companies in late-stage negotiations.
Management is monitoring macroeconomic risks, including potential recession and government policy changes, and may adjust business and financing plans as needed.
No specific forward-looking financial guidance provided.
PatentVest spin-out and potential strategic opportunities for the clearing platform expected in 2026.
Latest events from MDB Capital Holdings
- Building and launching IP-driven companies, with a strong IPO record and scalable platform focus.MDBH
Planet MicroCap Las Vegas 202617 Jun 2026 - Q1 2026 saw a $6.7M net loss, higher fee income, and strong broker dealer capital despite investment losses.MDBH
Q1 202614 May 2026 - AI-driven platform scaling, asset spinouts, and $22.3M cash position drive future growth.MDBH
Q4 20252 Apr 2026 - Public venture model delivers liquid, tax-advantaged access to high-growth companies.MDBH
Investor presentation16 Mar 2026 - IPO launches with LTIR, offering downside protection and incentives for long-term investors.MDBH
Status Update15 Jan 2026 - Invizyne IPO, deep tech pipeline, and investor growth drive expansion despite higher losses.MDBH
Q3 202412 Jan 2026 - eXoZymes IPO and deconsolidation clarify results as platform and investor base expand.MDBH
Q4 202426 Dec 2025 - Shareholders will vote on directors and auditor, with control held by Class B shares and strong governance oversight.MDBH
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and governance policies.MDBH
Proxy Filing2 Dec 2025